CN Patent

CN114369093B — 化合物的盐及其晶型

Assigned to Hutchmed Ltd · Expires 2024-12-17 · 1y expired

What this patent protects

本发明属于药学领域，提供了化合物(S)‑7‑(4‑(1‑(甲基磺酰基)‑哌啶‑4‑基)苯基)‑N‑(吗啉‑2‑基甲基)吡啶并[3,4‑b]吡嗪‑5‑胺的药学上可接受的盐及其晶型、溶剂合物及晶型、其药物组合物，及其制备方法和应用。

USPTO Abstract

本发明属于药学领域，提供了化合物(S)‑7‑(4‑(1‑(甲基磺酰基)‑哌啶‑4‑基)苯基)‑N‑(吗啉‑2‑基甲基)吡啶并[3,4‑b]吡嗪‑5‑胺的药学上可接受的盐及其晶型、溶剂合物及晶型、其药物组合物，及其制备方法和应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN114369093B
Jurisdiction
CN
Classification
—
Expires
2024-12-17
Drug substance claim
No
Drug product claim
No
Assignee
Hutchmed Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.